Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Trans-esophageal echocardiography is crucial for accurately diagnosing heart issues in lupus patients.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Proactive physical therapy improved mobility, reduced fatigue, and pain in lupus patients.

Mixed Connective Tissue Disease can develop from overlapping symptoms of several autoimmune diseases, making diagnosis complex.

Anti-CD19 therapy may help treat SLE and NMOSD.

Early recognition and management of gastrointestinal tuberculosis in lupus patients are crucial to prevent complications.

Catatonia can be a rare sign of lupus, needing careful diagnosis and treatment.

Purpura fulminans can signal underlying autoimmune disorders, not just infections.

Lupus patients in Ghana face healthcare challenges, and the Oyemam Autoimmune Foundation is working to improve awareness and support.

Bullous lupus can cause severe esophageal issues but responds well to corticosteroids and azathioprine.

Atypical symptoms in lupus can indicate different kidney issues.

Correct diagnosis is crucial for treating overlapping conditions like NMOSD and SLE effectively.

Middle-aged women with dilated cardiomyopathy should be screened for antiphospholipid syndrome.

Early recognition and a team approach are crucial for managing diffuse alveolar hemorrhage in antiphospholipid syndrome.

Antiphospholipid syndrome can severely damage adrenal glands, requiring early diagnosis and treatment.

SLE can cause unusual gastrointestinal symptoms, and immunosuppressive therapy can be effective.

Tirzepatide improved symptoms and hair regrowth in a man with folliculitis decalvans.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Monthly PRP therapy is more effective than daily minoxidil for alopecia areata.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Blue light might help treat skin conditions by affecting the skin's bacteria.

Basaloid follicular hamartoma is a rare, benign skin growth often misdiagnosed.

Baricitinib may effectively treat oral lichen planus.

Combining calcipotriol and PRP is most effective for treating Alopecia Areata.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

Method B with propylene glycol is better for stable low-concentration DPCP solutions for alopecia areata.

Decreased IGF-1R expression may contribute to sacrococcygeal pilonidal sinus development.